Denmark, one of the few European nations enjoying sustained economic growth, owes part of its success to the prominence of its local pharmaceutical giant, Novo Nordisk. In the past year, the company accounted for a significant 3.5% of Denmark's economic expansion, vastly surpassing regional benchmarks. Nonetheless, Novo Nordisk now confronts daunting challenges in maintaining its competitive edge in the highly competitive weight loss market in the United States.